China’s top 10 hematologic advances in 2020  

作　　者：Xiaochen Wang 

机构地区：[1]Managing Editor,Blood Science,State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Institute of Hematology&Blood Diseases Hospital,Chinese Academy of Medical Sciences,288 Nanjing Road,Tianjin 300020,China

出　　处：《Blood Science》2021年第2期27-28,共2页血液科学（英文）

摘　　要：From the research completed in China and published between January 1 and December 31,2020,25 candidates were selected through comprehensive retrieval by information agencies and recommendation by hematology experts.The final“China’s top 10 hematologic advances in 2020”were ranked by online voting from national academicians,the editorial board of the Chinese Journal of Hematology,and committee members from the Hematology Branch of Chinese Medical Association,Chinese Association of Blood Sciences,and Experimental Hematology Branch of Chinese Association of Pathophysiology.The result was announced on January 30,2021,at the first China Blood Development Conference.

关 键 词：BLOOD ranked ADVANCES 

分 类 号：F42[经济管理—产业经济]